What Are the Chances of Getting Thyroid Cancer From Mounjaro? (October 2026)

01 · The short version

The honest answer: there is no human percentage

In rodent studies tirzepatide caused thyroid C-cell tumours, but it is not known whether this applies to humans, and no increase has been shown in human trials.¹

That is different from saying the risk is proven to be zero. Our wider guide, Mounjaro and thyroid cancer: the complete UK guide, goes through the same evidence in more depth.

02 · Your decision

Is this relevant to me?

It matters most if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2. In that case, tell your prescriber at the start. They will weigh it in your assessment.¹ If neither applies, the precaution is still worth knowing about, but the product information does not ask for routine thyroid checks.

If you are weighing up risks in general, our pages on whether Mounjaro can cause cancer and on medullary thyroid cancer and Mounjaro cover the specifics. Ready to check suitability? Our free consultation is reviewed by a GPhC-registered prescriber, and you can see the Mounjaro pen page for current prices.

03 · Rodent findings

Why the warning exists

The warning exists because of animal data. In rodent studies tirzepatide caused thyroid C-cell tumours.¹ Regulators require a medicine's label to carry findings like this, even when it is unknown whether they apply to people.

The same product information states that no increase has been shown in human trials. Both statements are true together: an animal signal and no human signal so far. The patient information leaflet repeats the precaution, so it is worth reading before your first dose.¹³

04 · Who should tell us

Who should tell their prescriber first

Two histories need to be mentioned: medullary thyroid cancer in you or a close relative, and the inherited condition MEN 2.¹ Your prescriber will weigh this in your assessment.

Tell them about it during the consultation, together with your full medical history and medicine list. Other conditions are also reviewed before treatment. For example, a history of pancreatitis or gallbladder problems calls for extra care. You can read about pancreatitis and Mounjaro separately.

If you have a family history but are unsure what type of thyroid cancer a relative had, ask your GP or the relative's clinic if you can. Giving the prescriber accurate detail helps them judge suitability.

05 · Monitoring and symptoms

Monitoring, new symptoms and reporting

Routine thyroid monitoring is not required for most people on Mounjaro.¹ That means no scheduled thyroid scans or blood tests simply because you are taking it.

If you notice anything new or lasting, tell your prescriber. For severe, persistent stomach pain, swelling of the face or throat or difficulty breathing, get medical help straight away. You can also report a suspected side effect through the MHRA Yellow Card scheme.¹⁹

Our prescribing team carries out monthly reviews and follow-up assessments, and repeat orders re-check suitability, so there are regular points to raise concerns. For the wider picture, see how common side effects are on Mounjaro, since the everyday effects are different from this rare, precautionary one.

06 · Putting risk in context

Putting the risk in context

A balanced decision weighs benefit as well as risk. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages and individual results vary.²

In trials, weight loss also came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures. These are trial-average outcomes, not promises.

None of this cancels out a precaution that applies to you. It is the reason the decision belongs with a prescriber who sees your whole history. People who stop treatment should also know what to expect, which is covered in our page on whether you can withdraw from Mounjaro. After a final dose, tirzepatide takes roughly 4–5 weeks to clear the system.¹

07 · Beyond thyroid

Other safety points worth knowing

Thyroid is only one part of the safety picture. Mounjaro is not suitable for everyone: you should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

Mounjaro is also not known to damage the kidneys or liver directly, though severe vomiting or diarrhoea can cause dehydration, so keep fluids up. For how often digestive effects occur in practice, see how many people feel sick on Mounjaro.

08 · How ordering works

How ordering works if you decide to proceed

If, after reading this, you want to explore treatment, the process has three clear steps. First, complete the free online consultation, a short health questionnaire with no charge and no obligation. Second, a GPhC-registered prescriber reviews your answers. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses and ships your order, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in discreet, temperature-controlled packaging.

Mounjaro comes through official LillyDirect supply, as genuine KwikPens, and all six doses are in stock. You can buy Mounjaro online once approved, or browse all weight loss treatments. Mounjaro is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity, and individual results vary.